CATALYST BIOSCIENCES, INC.·4

Feb 13, 5:00 PM ET

Levy Howard 4

4 · CATALYST BIOSCIENCES, INC. · Filed Feb 13, 2019

Insider Transaction Report

Form 4
Period: 2019-02-11
Levy Howard
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-02-11$7.04/sh+2,485$17,49411,867 total
Footnotes (1)
  • [F1]Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 11, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION